ACRS logo

Aclaris Therapeutics (ACRS) Cash From Operations

Annual CFO

-$78.33 M
-$10.76 M-15.92%

December 31, 2023


Summary


Performance

ACRS Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherACRScash flowmetrics:

Quarterly CFO

$22.00 M
+$34.32 M+278.54%

September 30, 2024


Summary


Performance

ACRS Quarterly CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherACRScash flowmetrics:

TTM CFO

-$17.90 M
+$46.56 M+72.23%

September 30, 2024


Summary


Performance

ACRS TTM CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherACRScash flowmetrics:

Cash From Operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

ACRS Cash From Operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-15.9%+189.6%+80.3%
3 y3 years-102.7%+307.4%+59.2%
5 y5 years+22.3%+194.2%+75.1%

ACRS Cash From Operations Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-50.2%at lowat high+183.5%at high+80.3%
5 y5-year-102.7%+18.8%at high+183.5%at high+81.4%
alltimeall time-1492.0%+22.3%at high+170.3%-538.8%+83.8%

Aclaris Therapeutics Cash From Operations History

DateAnnualQuarterlyTTM
Sep 2024
-
$22.00 M(-278.5%)
-$17.90 M(-72.2%)
Jun 2024
-
-$12.32 M(-40.8%)
-$64.45 M(-11.4%)
Mar 2024
-
-$20.82 M(+207.9%)
-$72.79 M(-7.1%)
Dec 2023
-$78.33 M(+15.9%)
-$6.76 M(-72.5%)
-$78.33 M(-13.6%)
Sep 2023
-
-$24.56 M(+18.9%)
-$90.68 M(+22.6%)
Jun 2023
-
-$20.65 M(-21.6%)
-$73.94 M(+1.4%)
Mar 2023
-
-$26.35 M(+37.9%)
-$72.95 M(+8.0%)
Dec 2022
-$67.57 M(+29.6%)
-$19.11 M(+144.5%)
-$67.57 M(+3.1%)
Sep 2022
-
-$7.82 M(-60.3%)
-$65.53 M(-4.1%)
Jun 2022
-
-$19.67 M(-6.2%)
-$68.32 M(+12.2%)
Mar 2022
-
-$20.97 M(+22.8%)
-$60.87 M(+16.8%)
Dec 2021
-$52.13 M(+34.9%)
-$17.07 M(+61.0%)
-$52.13 M(+18.7%)
Sep 2021
-
-$10.61 M(-13.2%)
-$43.92 M(-3.4%)
Jun 2021
-
-$12.22 M(-0.1%)
-$45.46 M(+3.2%)
Mar 2021
-
-$12.23 M(+38.1%)
-$44.06 M(+14.0%)
Dec 2020
-$38.63 M(-59.9%)
-$8.86 M(-27.1%)
-$38.63 M(-23.0%)
Sep 2020
-
-$12.15 M(+12.3%)
-$50.17 M(-18.3%)
Jun 2020
-
-$10.82 M(+59.0%)
-$61.38 M(-14.7%)
Mar 2020
-
-$6.80 M(-66.6%)
-$71.93 M(-25.4%)
Dec 2019
-$96.44 M
-$20.39 M(-12.7%)
-$96.44 M(-6.6%)
DateAnnualQuarterlyTTM
Sep 2019
-
-$23.36 M(+9.3%)
-$103.30 M(-5.9%)
Jun 2019
-
-$21.38 M(-31.7%)
-$109.80 M(-0.4%)
Mar 2019
-
-$31.32 M(+14.9%)
-$110.26 M(+9.4%)
Dec 2018
-$100.81 M(+84.4%)
-$27.25 M(-8.7%)
-$100.81 M(+9.8%)
Sep 2018
-
-$29.86 M(+36.8%)
-$91.77 M(+21.3%)
Jun 2018
-
-$21.83 M(-0.2%)
-$75.63 M(+18.4%)
Mar 2018
-
-$21.87 M(+20.1%)
-$63.88 M(+16.9%)
Dec 2017
-$54.66 M(+58.0%)
-$18.21 M(+32.8%)
-$54.66 M(+22.8%)
Sep 2017
-
-$13.71 M(+36.1%)
-$44.52 M(+9.4%)
Jun 2017
-
-$10.08 M(-20.4%)
-$40.72 M(+0.9%)
Mar 2017
-
-$12.66 M(+56.8%)
-$40.37 M(+16.7%)
Dec 2016
-$34.60 M(+69.9%)
-$8.07 M(-18.5%)
-$34.60 M(+12.8%)
Sep 2016
-
-$9.90 M(+1.8%)
-$30.67 M(-2.1%)
Jun 2016
-
-$9.73 M(+41.2%)
-$31.33 M(+28.1%)
Mar 2016
-
-$6.89 M(+66.6%)
-$24.46 M(+20.1%)
Dec 2015
-$20.37 M(+166.7%)
-$4.14 M(-60.9%)
-$20.37 M(+25.5%)
Sep 2015
-
-$10.57 M(+269.3%)
-$16.23 M(+186.6%)
Jun 2015
-
-$2.86 M(+2.1%)
-$5.66 M(+102.1%)
Mar 2015
-
-$2.80 M
-$2.80 M
Dec 2014
-$7.64 M(+55.2%)
-
-
Dec 2013
-$4.92 M
-
-

FAQ

  • What is Aclaris Therapeutics annual cash flow from operations?
  • What is the all time high annual CFO for Aclaris Therapeutics?
  • What is Aclaris Therapeutics annual CFO year-on-year change?
  • What is Aclaris Therapeutics quarterly cash flow from operations?
  • What is the all time high quarterly CFO for Aclaris Therapeutics?
  • What is Aclaris Therapeutics quarterly CFO year-on-year change?
  • What is Aclaris Therapeutics TTM cash flow from operations?
  • What is the all time high TTM CFO for Aclaris Therapeutics?
  • What is Aclaris Therapeutics TTM CFO year-on-year change?

What is Aclaris Therapeutics annual cash flow from operations?

The current annual CFO of ACRS is -$78.33 M

What is the all time high annual CFO for Aclaris Therapeutics?

Aclaris Therapeutics all-time high annual cash flow from operations is -$4.92 M

What is Aclaris Therapeutics annual CFO year-on-year change?

Over the past year, ACRS annual cash flow from operations has changed by -$10.76 M (-15.92%)

What is Aclaris Therapeutics quarterly cash flow from operations?

The current quarterly CFO of ACRS is $22.00 M

What is the all time high quarterly CFO for Aclaris Therapeutics?

Aclaris Therapeutics all-time high quarterly cash flow from operations is $22.00 M

What is Aclaris Therapeutics quarterly CFO year-on-year change?

Over the past year, ACRS quarterly cash flow from operations has changed by +$46.56 M (+189.59%)

What is Aclaris Therapeutics TTM cash flow from operations?

The current TTM CFO of ACRS is -$17.90 M

What is the all time high TTM CFO for Aclaris Therapeutics?

Aclaris Therapeutics all-time high TTM cash flow from operations is -$2.80 M

What is Aclaris Therapeutics TTM CFO year-on-year change?

Over the past year, ACRS TTM cash flow from operations has changed by +$72.78 M (+80.26%)